OSR Holdings, Inc. (OSRH)
NASDAQ: OSRH · Real-Time Price · USD
1.060
+0.060 (6.00%)
At close: Jul 18, 2025, 4:00 PM
1.130
+0.070 (6.60%)
After-hours: Jul 18, 2025, 7:59 PM EDT
OSR Holdings Employees
As of December 31, 2024, OSR Holdings had 21 total employees, including 19 full-time and 2 part-time employees.
Employees
21
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$497,539
Market Cap
20.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
OSRH News
- 5 days ago - OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company - PRNewsWire
- 11 days ago - OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG - PRNewsWire
- 2 months ago - OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token - PRNewsWire
- 2 months ago - Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - PRNewsWire
- 3 months ago - Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology - PRNewsWire
- 3 months ago - OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies - PRNewsWire
- 4 months ago - Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma - PRNewsWire
- 4 months ago - OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - PRNewsWire